Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells

[1]  I. Weissman,et al.  Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes , 2013, Proceedings of the National Academy of Sciences.

[2]  R. Hoffman,et al.  Stromal cell-mediated inhibition of erythropoiesis can be attenuated by Sotatercept (ACE-011), an activin receptor type II ligand trap. , 2013, Experimental hematology.

[3]  W. Wagner,et al.  Tracking of replicative senescence in mesenchymal stem cells by colony-forming unit frequency. , 2013, Methods in molecular biology.

[4]  A. Trumpp,et al.  Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cells. , 2012, Blood.

[5]  Z. Zhao,et al.  The Different Immunoregulatory Functions of Mesenchymal Stem Cells in Patients with Low-Risk or High-Risk Myelodysplastic Syndromes , 2012, PloS one.

[6]  C. Steidl,et al.  Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations. , 2012, Blood.

[7]  Marcos González,et al.  Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients , 2012, Haematologica.

[8]  E. Carasevici,et al.  Intrinsic growth deficiencies of mesenchymal stromal cells in myelodysplastic syndromes. , 2012, Stem cells and development.

[9]  Peter A. Jones.  Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[10]  M. Raaijmakers.  Myelodysplastic syndromes: revisiting the role of the bone marrow microenvironment in disease pathogenesis , 2012, International Journal of Hematology.

[11]  John M. Ashton,et al.  Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. , 2011, Blood.

[12]  Ulrich Keilholz,et al.  Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts. , 2011, Blood.

[13]  E. Carasevici,et al.  Focal adhesion protein abnormalities in myelodysplastic mesenchymal stromal cells. , 2011, Experimental cell research.

[14]  S. Méndez-Ferrer,et al.  Stem Cell Interactions in a Bone Marrow Niche , 2011, Current osteoporosis reports.

[15]  P. Bianco.  Bone and the hematopoietic niche: a tale of two stem cells. , 2011, Blood.

[16]  Frank Lyko,et al.  Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging. , 2011, Blood.

[17]  D. Scadden,et al.  A Novel Role for CCL3 (MIP-1α) in Myeloma-induced Bone Disease via Osteocalcin Downregulation and Inhibition of Osteoblast Function , 2011, Leukemia.

[18]  H. Deeg,et al.  The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes. , 2010, Blood.

[19]  P. Woll,et al.  Persistent malignant stem cells in del(5q) myelodysplasia in remission. , 2010, The New England journal of medicine.

[20]  Ben D. MacArthur,et al.  Mesenchymal and haematopoietic stem cells form a unique bone marrow niche , 2010, Nature.

[21]  C. Mamalaki,et al.  Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes. , 2010, Stem cells and development.

[22]  B. Korn,et al.  Aging and Chronic Sun Exposure Cause Distinct Epigenetic Changes in Human Skin , 2010, PLoS genetics.

[23]  S. Kashima,et al.  Effects of high-dose chemotherapy on bone marrow multipotent mesenchymal stromal cells isolated from lymphoma patients. , 2010, Experimental hematology.

[24]  Wolfgang Wagner,et al.  Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. , 2010, Genome research.

[25]  Charles P. Lin,et al.  Bone progenitor dysfunction induces myelodysplasia and secondary leukemia , 2010, Nature.

[26]  R. Kalluri,et al.  Contribution of bone microenvironment to leukemogenesis and leukemia progression , 2009, Leukemia.

[27]  U. Germing,et al.  Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes , 2009, European journal of haematology.

[28]  B. Brors,et al.  The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence , 2009, Leukemia.

[29]  J. Hernández-Rivas,et al.  Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q− syndrome , 2009, Leukemia.

[30]  U. Germing,et al.  Meningioma 1 gene is differentially expressed in CD34 positive cells from bone marrow of patients with myelodysplastic syndromes with the highest expression in refractory anemia with excess of blasts and secondary acute myeloid leukemia , 2009, Leukemia & lymphoma.

[31]  M. Bitzer,et al.  Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS. , 2008, Blood.

[32]  V. Velebný,et al.  Hyaluronan influence on the onset of chondrogenic differentiation of mesenchymal stem cells. , 2008, Neuro endocrinology letters.

[33]  H. Mayani,et al.  Functional analysis of myelodysplastic syndromes-derived mesenchymal stem cells. , 2008, Leukemia research.

[34]  Rainer Haas,et al.  Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes , 2008, Annals of Hematology.

[35]  K. Pienta,et al.  The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites , 2008, Leukemia.

[36]  F. Uher,et al.  Inappropriate notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes , 2008, Pathology & Oncology Research.

[37]  A. Chess,et al.  Gene Body-Specific Methylation on the Active X Chromosome , 2007, Science.

[38]  E. Thiel,et al.  Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia. , 2007, Experimental hematology.

[39]  H. Mayani,et al.  Chromosomal abnormalities in marrow stromal cells from myelodysplastic syndromes (MDS). , 2006, Blood.

[40]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[41]  S. Flamant,et al.  Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro , 2005, Oncogene.

[42]  R. Kapur,et al.  Role of c-Kit and erythropoietin receptor in erythropoiesis. , 2005, Critical reviews in oncology/hematology.

[43]  H. Mayani,et al.  Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization. , 2005, Leukemia research.

[44]  A. Kispert,et al.  The T-box transcription factor Tbx15 is required for skeletal development , 2005, Mechanisms of Development.

[45]  S. Tauro,et al.  Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes , 2002, Leukemia.

[46]  A. Raza,et al.  Successful establishment of long-term bone marrow cultures in 103 patients with myelodysplastic syndromes. , 2001, Leukemia research.

[47]  K. Mills,et al.  Abnormalities of adherent layers grown from bone marrow of patients with myelodysplasia , 2000, British journal of haematology.

[48]  H. Deeg,et al.  Negative Regulators of Hemopoiesis and Stroma Function in Patients with Myelodysplastic Syndrome , 2000, Leukemia & lymphoma.

[49]  A. Ibatici,et al.  Low plasma stem cell factor levels correlate with in vitro leukemic growth in myelodysplastic syndromes. , 1999, Leukemia research.

[50]  R. Recker,et al.  Bone remodeling alterations in myelodysplastic syndrome. , 1996, Bone.

[51]  H. Broxmeyer,et al.  Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. , 1980, Blood.